Rexulti, the first drug to relieve Alzheimer's emotions - TimesKuwait

The US Food and Drug Administration (FDA) has granted fast-track approval of the first drug aimed at relieving the emotions associated with Alzheimer’s disease. The FDA published, on its official website, a statement confirming the approval of Otsuka Pharmaceutical Company and Lundbeck, producers of oral Rexulti tablets to relieve the emotions associated with Alzheimer’s disease, […]

First FDA Approved Medication for Agitation Associated with Alzheimer's Dementia – Psychiatry Education Forum

This Antipsychotic Drug Can Now Be Used to Treat Agitation in Alzheimer's Patients

First FDA Approved Medication for Agitation Associated with Alzheimer's Dementia – Psychiatry Education Forum

Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation

Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation

Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation

This Antipsychotic Drug Can Now Be Used to Treat Agitation in Alzheimer's Patients

FDA Approves First-Ever Drug for Agitation Associated with Alzheimer's Dementia

First FDA Approved Medication for Agitation Associated with Alzheimer's Dementia – Psychiatry Education Forum

The Madness of Pop Psychiatry - by Nick Jikomes, PhD

Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation

FDA Approves First Drug to Treat Dementia-Associated Agitation in AD Patients

FDA Approves First-Ever Drug for Agitation Associated with Alzheimer's Dementia